Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.45 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 4/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NAMPT | P43490 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25735183 | 1.00 | PABPC1 (0.45) | PABPC1EIF4HKEAP1NFE2L2KDM4E | |
| SCHEMBL25735148 | 1.00 | PABPC1 (0.45) | PABPC1EIF4HKEAP1NFE2L2KDM4E | |
| SCHEMBL25735188 | 1.00 | PABPC1 (0.45) | PABPC1EIF4HKEAP1NFE2L2KDM4E | |
| SCHEMBL19834828 | 0.93 | PABPC1 (0.50) | PABPC1EIF4HKEAP1NFE2L2KDM4E | |
| SCHEMBL25735164 | 0.91 | CDK2 (0.53) | PABPC1EIF4HKEAP1NFE2L2KDM4E | |
| SCHEMBL25735198 | 0.91 | CDK2 (0.53) | PABPC1EIF4HKEAP1NFE2L2KDM4E | |
| SCHEMBL25735204 | 0.89 | KDM4E (0.41) | PABPC1EIF4HKDM4EALDH1A1ABL1 | |
| SCHEMBL25735159 | 0.89 | KDM4E (0.41) | PABPC1EIF4HKDM4EALDH1A1ABL1 | |
| SCHEMBL25735207 | 0.88 | PABPC1 (0.41) | PABPC1EIF4HKDM4EALDH1A1ABL1 | |
| SCHEMBL25735162 | 0.88 | PABPC1 (0.41) | PABPC1EIF4HKDM4EALDH1A1ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192651-A1 | Pyrrolidine Derivative and Use Thereof | WANG, ZHEMING (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230192651-A1 | Pyrrolidine Derivative and Use Thereof | WANG, ZHEMING (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192651-A1 | Pyrrolidine Derivative and Use Thereof | NAMPT, NAPRT, NNMT | PABPC1 1223/4885EIF4H 3724/4885KEAP1 2515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.